Works matching AU Abada, Paolo

Results: 20

Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α‐fetoprotein: Outcomes by treatment‐emergent ascites.

Published in:

Hepatology Research, 2021, v. 51, n. 6, p. 715, doi. 10.1111/hepr.13638

By:

Kudo, Masatoshi;
Ikeda, Masafumi;
Galle, Peter R.;
Yamashita, Tatsuya;
Finn, Richard S.;
Liang, Kun;
Wang, Chunxiao;
Sakaguchi, Sachi;
Abada, Paolo;
Widau, Ryan C.;
Zhu, Andrew X.

Publication type:

Article

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.

Published in:

2018

By:

Chau, Ian;
Park, Joon Oh;
Ryoo, Baek-Yeol;
Yen, Chia-Jui;
Poon, Ronnie;
Pastorelli, Davide;
Blanc, Jean-Frédéric;
Kudo, Masatoshi;
Pfiffer, Tulio;
Hatano, Etsuro;
Chung, Hyun Cheol;
Kopeckova, Katerina;
Phelip, Jean-Marc;
Brandi, Giovanni;
Ohkawa, Shinichi;
Li, Chung-Pin;
Okusaka, Takuji;
Hsu, Yanzhi;
Abada, Paolo B.;
Zhu, Andrew X.

Publication type:

journal article

Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States: a real-world database study.

Published in:

Leukemia & Lymphoma, 2023, v. 64, n. 5, p. 1005, doi. 10.1080/10428194.2023.2190436

By:

Eyre, Toby A.;
Hess, Lisa M.;
Sugihara, Tomoko;
He, Dan;
Khanal, Manoj;
Pagel, John M.;
Walgren, Richard A.;
B. Abada, Paolo;
Konig, Heiko;
Roeker, Lindsey E.;
Mato, Anthony

Publication type:

Article

Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605

By:

Kudo, Masatoshi;
Finn, Richard S.;
Morimoto, Manabu;
Rau, Kun-Ming;
Ikeda, Masafumi;
Yen, Chia-Jui;
Galle, Peter R.;
Llovet, Josep M.;
Daniele, Bruno;
Lim, Ho Yeong;
McIlwain, David W.;
Yoshikawa, Reigetsu;
Nakamura, Kenichi;
Liang, Kun;
Wang, Chunxiao;
Abada, Paolo;
Widau, Ryan C.;
Zhu, Andrew X.

Publication type:

Article

Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605

By:

Kudo, Masatoshi;
Finn, Richard S.;
Morimoto, Manabu;
Rau, Kun-Ming;
Ikeda, Masafumi;
Yen, Chia-Jui;
Galle, Peter R.;
Llovet, Josep M.;
Daniele, Bruno;
Lim, Ho Yeong;
McIlwain, David W.;
Yoshikawa, Reigetsu;
Nakamura, Kenichi;
Liang, Kun;
Wang, Chunxiao;
Abada, Paolo;
Widau, Ryan C.;
Zhu, Andrew X.

Publication type:

Article

Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 4, p. 440, doi. 10.1159/000506946

By:

Yen, Chia-Jui;
Kudo, Masatoshi;
Lim, Ho-Yeong;
Hsu, Chih-Hung;
Vogel, Arndt;
Brandi, Giovanni;
Cheng, Rebecca;
Nitu, Ioana Simona;
Abada, Paolo;
Hsu, Yanzhi;
Zhu, Andrew X.;
Kang, Yoon-Koo

Publication type:

Article

Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study.

Published in:

2023

By:

Mato, Anthony R.;
Hess, Lisa M.;
Chen, Yongmei;
Abada, Paolo B.;
Konig, Heiko;
Pagel, John M.;
Walgren, Richard A.

Publication type:

journal article

Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology.

Published in:

Liver International, 2021, v. 41, n. 11, p. 2759, doi. 10.1111/liv.14994

By:

Galle, Peter R.;
Kudo, Masatoshi;
Llovet, Josep M.;
Finn, Richard S.;
Karwal, Mark;
Pezet, Denis;
Kim, Tae‐You;
Yang, Tsai‐Sheng;
Lonardi, Sara;
Tomasek, Jiri;
Phelip, Jean‐Marc;
Touchefeu, Yann;
Koh, Su‐Jin;
Stirnimann, Guido;
Liang, Kun;
Ogburn, Kenyon D.;
Wang, Chunxiao;
Abada, Paolo;
Widau, Ryan C.;
Zhu, Andrew X.

Publication type:

Article

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab.

Published in:

Liver International, 2021, v. 41, n. 3, p. 598, doi. 10.1111/liv.14731

By:

Reig, Maria;
Galle, Peter R.;
Kudo, Masatoshi;
Finn, Richard;
Llovet, Josep M.;
Metti, Andrea L.;
Schelman, William R.;
Liang, Kun;
Wang, Chunxiao;
Widau, Ryan C.;
Abada, Paolo;
Zhu, Andrew X.

Publication type:

Article

Issue Cover.

Published in:

Liver International, 2019, v. 39, n. 12, p. i, doi. 10.1111/liv.14277

By:

Galle, Peter R.;
Foerster, Friedrich;
Kudo, Masatoshi;
Chan, Stephen L.;
Llovet, Josep M.;
Qin, Shukui;
Schelman, William R.;
Chintharlapalli, Sudhakar;
Abada, Paolo B.;
Sherman, Morris;
Zhu, Andrew X.

Publication type:

Article

Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma.

Published in:

Liver International, 2019, v. 39, n. 12, p. 2214, doi. 10.1111/liv.14223

By:

Galle, Peter R.;
Foerster, Friedrich;
Kudo, Masatoshi;
Chan, Stephen L.;
Llovet, Josep M.;
Qin, Shukui;
Schelman, William R.;
Chintharlapalli, Sudhakar;
Abada, Paolo B.;
Sherman, Morris;
Zhu, Andrew X.

Publication type:

Article

Evaluating clinical impact of a shortened infusion duration for ramucirumab: a model-based approach.

Published in:

Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 635, doi. 10.1007/s00280-020-04223-9

By:

Gao, Ling;
Lau, Yiu-Keung;
Wei, Ran;
O'Brien, Lisa;
Long, Amanda;
Piao, Yongzhe;
Abada, Paolo

Publication type:

Article

Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library.

Published in:

Journal of Patient-Reported Outcomes, 2024, v. 8, p. 1, doi. 10.1186/s41687-024-00683-2

By:

Markowitz, Jessica T.;
Mazerolle, Flora;
Lovell, Teya;
Hess, Lisa M.;
Abada, Paolo B.;
Regnault, Antoine;
Payakachat, Nalin

Publication type:

Article

Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study.

Published in:

Current Medical Research & Opinion, 2021, v. 37, n. 10, p. 1769, doi. 10.1080/03007995.2021.1940908

By:

Taniguchi, Hiroya;
Yoshino, Takayuki;
Yamaguchi, Kensei;
Yamazaki, Kentaro;
Nixon, Andrew B.;
Tabernero, Josep;
Van Cutsem, Eric;
Robling, Kim R.;
Abada, Paolo B.;
Hozak, Rebecca R.;
Siegel, Robert;
Fill, Jeffrey A.;
Wijayawardana, Sameera;
Walgren, Richard A.;
Giles, Brendan;
Jones, Abby;
Pitts, Kelly R.;
Drove, Nora;
Muro, Kei

Publication type:

Article

Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study.

Published in:

Advances in Hematology, 2022, p. 1, doi. 10.1155/2022/8262787

By:

Hess, Lisa M.;
Chen, Yongmei;
Abada, Paolo B.;
Konig, Heiko;
Walgren, Richard A.

Publication type:

Article

Regulation of Cisplatin Cytotoxicity by Cu Influx Transporters.

Published in:

Metal-Based Drugs, 2010, v. 2010, p. 1, doi. 10.1155/2010/317581

By:

Abada, Paolo;
Howell, Stephen B.

Publication type:

Article

Optimizing the Dosing Regimen of Cetuximab and Ramucirumab Using the Model‐Informed Drug Development Paradigm.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 1, p. 77, doi. 10.1002/cpt.2919

By:

Ni, Lan;
Khan, Azhar Zaman;
Long, Amanda;
Gao, Ling;
Toms, Nikki;
Gonzalez‐Gugel, Elena;
Holsmer‐Brand, Susan;
Lin, Yong;
Abada, Paolo;
Dickin, Sandra;
O'Dea, Declan;
Wei, Ran;
Jen, Min‐Hua;
Aggarwal, Himani

Publication type:

Article

Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study.

Published in:

Journal of Gastric Cancer, 2023, v. 23, n. 2, p. 289, doi. 10.5230/jgc.2023.23.e15

By:

Takatsugu Ogata;
Yukiya Narita;
Wainberg, Zev A.;
Van Cutsem, Eric;
Kensei Yamaguchi;
Yongzhe Piao;
Yumin Zhao;
Peterson, Patrick M.;
Wijayawardana, Sameera R.;
Paolo Abada;
Anindya Chatterjee;
Kei Muro

Publication type:

Article

Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells.

Published in:

PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087444

By:

Abada, Paolo B.;
Howell, Stephen B.

Publication type:

Article

Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies.

Published in:

Oncologist, 2021, v. 26, n. 9, p. e1538, doi. 10.1002/onco.13836

By:

Mansoor, Wasat;
Roeland, Eric J.;
Chaudhry, Aafia;
Liepa, Astra M.;
Wei, Ran;
Knoderer, Holly;
Abada, Paolo;
Chatterjee, Anindya;
Klempner, Samuel J.

Publication type:

Article